⚕ GalenOps field
←

704-1017

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
704 (USA) · Dr. Tanaka
consented 2013-10-06

AEs
8
Serious
0
Dropout signal
–

Adverse events

mild assessed

Mild CARDIAC DISORDER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-01 (study day 27.0); relationship: NONE

mild assessed

Mild INFLUENZA — outcome: RECOVERED/RESOLVED; onset 2013-11-01 (study day 27.0); relationship: NONE

mild assessed

Mild MYOCARDIAL INFARCTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-19 (study day 14.0); relationship: NONE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-05 (study day 31.0); relationship: PROBABLE

mild assessed

Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-11-05 (study day 31.0); relationship: PROBABLE

mild assessed

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-05 (study day 31.0); relationship: PROBABLE

mild assessed

Mild RASH — outcome: RECOVERED/RESOLVED; onset 2013-11-05 (study day 31.0); relationship: PROBABLE

mild assessed

Mild VENTRICULAR SEPTAL DEFECT — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-19 (study day 14.0); relationship: NONE

Data queries

No data queries.